MRKR – Marker Therapeutics Inc
Marker Therapeutics, Inc.MRKR
$1.15Name : Marker Therapeutics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $12,315,350.00
EPSttm : -1.19
Marker Therapeutics, Inc.
$1.15
6.48%$0.07Float Short %
5.36
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
EPS Last/This Y
-0.1
EPS This/Next Y
-0.38
Price
1.15
Target Price
8.17
Analyst Recom
1
Performance Q
-56.77
Relative Volume
0.26
Beta
1.31
Ticker: MRKR
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-03-20 | MRKR | 1.22 | N/A | N/A | 0 |
| 2025-03-21 | MRKR | 1.266 | N/A | N/A | 0 |
| 2025-03-24 | MRKR | 1.3 | N/A | N/A | 0 |
| 2025-03-25 | MRKR | 1.22 | N/A | N/A | 0 |
| 2025-03-26 | MRKR | 1.18 | N/A | N/A | 0 |
| 2025-03-27 | MRKR | 1.345 | N/A | N/A | 0 |
| 2025-03-28 | MRKR | 1.273 | N/A | N/A | 0 |
| 2025-03-31 | MRKR | 1.213 | N/A | N/A | 0 |
| 2025-04-01 | MRKR | 1.14 | N/A | N/A | 0 |
| 2025-04-02 | MRKR | 1.2 | N/A | N/A | 0 |
| 2025-04-03 | MRKR | 1.1 | N/A | N/A | 0 |
| 2025-04-04 | MRKR | 1.01 | N/A | N/A | 0 |
| 2025-04-07 | MRKR | 0.999 | N/A | N/A | 0 |
| 2025-04-08 | MRKR | 1 | N/A | N/A | 0 |
| 2025-04-09 | MRKR | 1.1 | N/A | N/A | 0 |
| 2025-04-10 | MRKR | 1.02 | N/A | N/A | 0 |
| 2025-04-11 | MRKR | 1.015 | N/A | N/A | 0 |
| 2025-04-14 | MRKR | 1.11 | N/A | N/A | 0 |
| 2025-04-15 | MRKR | 1.167 | N/A | N/A | 0 |
| 2025-04-16 | MRKR | 1.06 | N/A | N/A | 0 |
| 2025-04-17 | MRKR | 1.1655 | N/A | N/A | 0 |
| 2025-04-18 | MRKR | 1.15 | N/A | N/A | 0 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-03-20 | MRKR | 1.25 | - | - | -1.05 |
| 2025-03-21 | MRKR | 1.27 | - | - | -1.05 |
| 2025-03-24 | MRKR | 1.28 | - | - | -1.05 |
| 2025-03-25 | MRKR | 1.19 | - | - | -1.05 |
| 2025-03-26 | MRKR | 1.16 | - | - | -1.05 |
| 2025-03-27 | MRKR | 1.37 | - | - | -1.05 |
| 2025-03-28 | MRKR | 1.27 | - | - | -1.05 |
| 2025-03-31 | MRKR | 1.23 | - | - | -1.05 |
| 2025-04-01 | MRKR | 1.14 | - | - | -1.05 |
| 2025-04-02 | MRKR | 1.20 | - | - | -1.05 |
| 2025-04-03 | MRKR | 1.10 | - | - | -1.05 |
| 2025-04-04 | MRKR | 1.01 | -18.5 | - | -1.29 |
| 2025-04-07 | MRKR | 1.00 | -18.5 | - | -1.29 |
| 2025-04-08 | MRKR | 1.05 | -18.5 | - | -1.29 |
| 2025-04-09 | MRKR | 1.07 | -18.5 | - | -1.29 |
| 2025-04-10 | MRKR | 1.03 | -18.5 | - | -1.29 |
| 2025-04-11 | MRKR | 1.02 | -18.5 | - | -1.29 |
| 2025-04-14 | MRKR | 1.10 | -18.5 | - | -1.29 |
| 2025-04-15 | MRKR | 1.17 | -18.5 | - | -1.29 |
| 2025-04-16 | MRKR | 1.07 | -18.5 | - | -1.29 |
| 2025-04-17 | MRKR | 1.15 | -18.5 | - | -1.29 |
| 2025-04-18 | MRKR | 1.15 | -18.5 | - | -1.29 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-03-20 | MRKR | 21.18 | 2.45 | 1.85 |
| 2025-03-21 | MRKR | 21.18 | 2.45 | 1.85 |
| 2025-03-24 | MRKR | 21.17 | 2.45 | 1.85 |
| 2025-03-25 | MRKR | 21.17 | 2.45 | 1.85 |
| 2025-03-26 | MRKR | 21.17 | 2.45 | 4.99 |
| 2025-03-27 | MRKR | 21.18 | 2.45 | 4.99 |
| 2025-03-28 | MRKR | 21.18 | 2.45 | 4.99 |
| 2025-03-31 | MRKR | 21.18 | 2.45 | 4.99 |
| 2025-04-01 | MRKR | 21.18 | 2.45 | 4.99 |
| 2025-04-02 | MRKR | 21.18 | 2.45 | 4.99 |
| 2025-04-03 | MRKR | 21.17 | 2.45 | 4.99 |
| 2025-04-04 | MRKR | 21.18 | 2.45 | 4.99 |
| 2025-04-07 | MRKR | 21.17 | 2.45 | 4.99 |
| 2025-04-08 | MRKR | 21.17 | 2.45 | 4.99 |
| 2025-04-09 | MRKR | 21.17 | 2.45 | 4.99 |
| 2025-04-10 | MRKR | 21.18 | 2.45 | 5.36 |
| 2025-04-11 | MRKR | 21.17 | 2.45 | 5.36 |
| 2025-04-14 | MRKR | 21.17 | 2.45 | 5.36 |
| 2025-04-15 | MRKR | 21.17 | 2.45 | 5.36 |
| 2025-04-16 | MRKR | 21.17 | 2.45 | 5.36 |
| 2025-04-17 | MRKR | 21.17 | 2.45 | 5.36 |
| 2025-04-18 | MRKR | 21.17 | 2.45 | 5.36 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
-0.28
Avg. EPS Est. Next Quarter
-0.48
Insider Transactions
21.17
Institutional Transactions
2.45
Beta
1.31
Average Sales Estimate Current Quarter
1
Average Sales Estimate Next Quarter
Fair Value
Quality Score
23
Growth Score
25
Sentiment Score
34
Actual DrawDown %
97
Max Drawdown 5-Year %
-98
Target Price
8.17
P/E
Forward P/E
PEG
P/S
1.87
P/B
0.66
P/Free Cash Flow
EPS
-1.2
Average EPS Est. Cur. Y
-1.29
EPS Next Y. (Est.)
-1.67
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-162.82
Relative Volume
0.26
Return on Equity vs Sector %
-77.8
Return on Equity vs Industry %
-64.4
EPS 1 7Days Diff
0.1
EPS 1 30Days Diff
0.9
EBIT Estimation
Marker Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 5
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its multi tumor associated antigen-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens. The company also develops MT-401-OTS for the treatment of acute myeloid leukemia; and MT-601 to treat lymphoma and pancreatic cancer. Marker Therapeutics, Inc. is headquartered in Houston, Texas.
stock quote shares MRKR – Marker Therapeutics Inc Stock Price stock today
news today MRKR – Marker Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch MRKR – Marker Therapeutics Inc yahoo finance google finance
stock history MRKR – Marker Therapeutics Inc invest stock market
stock prices MRKR premarket after hours
ticker MRKR fair value insiders trading